Medicine & Life Sciences
Glioblastoma
100%
calpain inhibitors
87%
diallyl trisulfide
86%
calpeptin
85%
Autoimmune Experimental Encephalomyelitis
74%
Calpain
74%
Multiple Sclerosis
63%
Temporal Lobe Epilepsy
59%
Spinal Cord Injuries
56%
Brain Neoplasms
54%
((1S)-1-((((1S)-1-benzyl-3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester
52%
Inflammation
51%
Animal Models
47%
Heterografts
42%
Cell Death
39%
Drug Resistant Epilepsy
38%
Melatonin Receptors
36%
Therapeutics
35%
Spinal Cord
34%
Conjugated (USP) Estrogens
34%
Anaplastic Lymphoma Kinase
33%
Optic Neuritis
32%
Calcium-Binding Proteins
31%
Astrocytes
30%
SCID Mice
29%
Histone Deacetylase Inhibitors
29%
Histone Deacetylases
29%
Immunomodulation
29%
Melatonin
27%
Cerebral Hemorrhage
27%
Erythropoietin
26%
Optic Nerve
26%
Neoplasms
25%
Calbindin 1
25%
GTP-Binding Proteins
25%
Blood-Brain Barrier
24%
Motor Neurons
24%
Estrogen Receptors
24%
Matrix Metalloproteinases
24%
Names
24%
Drug Resistance
23%
Apoptosis
22%
Glutamic Acid
22%
Parvalbumins
21%
Neuroprotection
20%
Seizures
19%
Down-Regulation
17%
Neuroprotective Agents
17%
Regulatory T-Lymphocytes
16%
Membranes
15%
Chemical Compounds
Cord
93%
Calpain Inhibitor
88%
Calpeptin
52%
Diallyl Trisulfide
45%
Lethal
36%
Oncogenic
35%
Cell Death
35%
Prescription Drug
21%
Estrogen
16%
Developmental
15%
Reduction
14%
Tyrosine
11%
Water Soluble
9%
Neuroprotective
9%
MicroRNA
6%